🔗 Share this article The State of Texas Attorney General Takes Legal Action Against Acetaminophen Makers Over Autism Spectrum Claims Ken Paxton, a Trump ally seeking election to the United States Senate, alleged the drug companies of concealing the risks of Tylenol The top legal official in Texas Ken Paxton is suing the producers of acetaminophen, alleging the corporations concealed safety concerns that the medication presented to children's neurological development. The lawsuit comes four weeks after Former President Trump advocated an unproven link between consuming Tylenol - also known as paracetamol - while pregnant and autism spectrum disorder in young ones. The attorney general is filing suit against J&J, which formerly manufactured the drug, the exclusive pain medication recommended for women during pregnancy, and the current manufacturer, which currently produces it. In a declaration, he claimed they "betrayed America by making money from suffering and pushing pills regardless of the potential hazards." Kenvue says there is insufficient reliable data linking Tylenol to autism spectrum disorder. "These corporations lied for decades, knowingly endangering countless individuals to increase profits," the attorney general, from the Republican party, declared. The manufacturer said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the safety of acetaminophen and the likely effects that could have on the health of US mothers and children." On its official site, Kenvue also mentioned it had "continuously evaluated the relevant science and there is no credible data that indicates a established connection between taking acetaminophen and autism spectrum disorder." Organizations speaking for medical professionals and healthcare providers share this view. The American College of Obstetricians and Gynecologists has stated acetaminophen - the primary component in Tylenol - is a restricted selection for pregnant women to manage pain and fever, which can pose major wellness concerns if left untreated. "In more than two decades of studies on the use of paracetamol in pregnancy, no reliable research has definitively established that the use of acetaminophen in any trimester of pregnancy leads to neurological conditions in children," the association said. This legal action references current declarations from the Trump administration in arguing the drug is allegedly unsafe. Last month, Trump generated worry from public health officials when he advised expectant mothers to "struggle intensely" not to consume acetaminophen when sick. Federal regulators then published an announcement that physicians should contemplate reducing the consumption of acetaminophen, while also stating that "a proven link" between the medication and autism spectrum disorder in minors has not been proven. Health Secretary Kennedy, who supervises the FDA, had vowed in spring to undertake "a massive testing and research effort" that would establish the source of autism in a limited time. But authorities cautioned that finding a unique factor of autism - considered by experts to be the outcome of a intricate combination of inherited and surrounding conditions - would not be simple. Autism spectrum disorder is a category of lifelong neurodivergence and disability that affects how individuals experience and relate to the surroundings, and is diagnosed using medical professional evaluations. In his lawsuit, Paxton - aligned with the former president who is running for US Senate - asserts Kenvue and J&J "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism spectrum disorder. The case seeks to make the firms "destroy any promotional materials" that states Tylenol is secure for women during pregnancy. The court case mirrors the complaints of a group of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who sued the producers of acetaminophen in 2022. Judicial authorities threw out the legal action, stating studies from the family's specialists was lacking definitive proof.